Enanta Pharmaceuticals Inc (ENTA) — Cash Flow Reinvestment Rate
Enanta Pharmaceuticals Inc (ENTA) has a Cash Flow Reinvestment Rate of 1.52x as of June 2025, reinvesting $26.64 Million (capex $155.00K plus investments $-26.48 Million) from operating cash flow of $17.51 Million. Explore how much does Enanta Pharmaceuticals Inc reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Enanta Pharmaceuticals Inc Cash Flow Reinvestment Rate (2011–2020)
Historical reinvestment intensity for Enanta Pharmaceuticals Inc across 10 annual periods. Also explore Enanta Pharmaceuticals Inc (ENTA) total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Enanta Pharmaceuticals Inc (2011–2020)
Year-by-year capital reinvestment analysis for Enanta Pharmaceuticals Inc. For live market cap and broader valuation context, see Enanta Pharmaceuticals Inc market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 3.21x | $22.72 Million | $7.09 Million | $1.45 Million | ▲ +164.2% |
| 2019 | 1.21x | $86.66 Million | $71.42 Million | $5.42 Million | ▼ -7.6% |
| 2018 | 1.31x | $38.38 Million | $29.22 Million | $2.98 Million | ▲ +1412.8% |
| 2017 | 0.09x | $4.57 Million | $52.65 Million | $2.51 Million | ▼ -92.9% |
| 2016 | 1.22x | $43.66 Million | $35.81 Million | $4.74 Million | ▲ +6.2% |
| 2015 | 1.15x | $88.02 Million | $76.67 Million | $2.34 Million | ▲ +808.5% |
| 2014 | 0.13x | $2.55 Million | $20.18 Million | $1.03 Million | ▼ -98.1% |
| 2013 | 6.50x | $69.22 Million | $10.65 Million | $606.00K | ▲ +58229.0% |
| 2012 | 0.01x | $252.00K | $22.62 Million | $252.00K | ▼ -39.9% |
| 2011 | 0.02x | $445.00K | $24.02 Million | $445.00K | — |